Researchers have used artificial intelligence to investigate network-based relationships between COVID-19 and Alzheimer’s disease, in the hope of informing therapeutic […]
Earlier this week the U.S. Food and Drug Administration approved the first new treatment for Alzheimer’s disease in almost 20 […]
The National Institutes of Health (NIH) have funded a five-year effort to use state-of-the-art artificial intelligence methods to study Alzheimer’s […]
In a lengthy statement released on Wednesday, FDA staff appeared to endorse Biogen’s treatment for Alzheimer’s disease. If approved, this […]
A recent review, in Nature Reviews Neurology, has provided an overview of the promising compounds for clinical trials in individuals […]
A recent review, published in the Journal of Pharmacy and Pharmacology, provides an overview of drug repositioning and the new […]
